Data as of Jul 23
| 0.00 / 0.00%|
The 21 analysts offering 12-month price forecasts for Celgene Corp have a median target of 95.00, with a high estimate of 126.00 and a low estimate of 51.00. The median estimate represents a +6.60% increase from the last price of 89.12.
The current consensus among 26 polled investment analysts is to Buy stock in Celgene Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.